Zomedica Corp.Pembelian
ZOM reaching denouement in symmetrical triangle
ZOM is about to reach the endpoint of it's symmetrical triangle. ZOM has been in the news a lot recently with the Carole Baskin mention and it also has a heavily patented technology coming out at the end of March. This stock has a great leadership team as well. Do you own do dill but I think this one is going up! Price target is $2.50.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.